Press Release National
Press Release
Reproductive Freedom for All Responds as Supreme Court Takes Up Medication Abortion Case
Washington, DC — Today, the U.S. Supreme Court agreed to hear anti-abortion extremists’ case to determine whether to impose restrictions on mifepristone. While this safe, effective medication remains available for now, if the Court rules in favor of anti-abortion groups, it could roll back abortion access in our country even further by placing extreme and medically unnecessary restrictions on mifepristone in all 50 states.
Reproductive Freedom for All President and CEO Mini Timmaraju released the following statement:
“This case should never have made it this far. The whims of extremist judges should not override two decades of settled science and safe use. The Court’s conservative justices have already ended Roe v. Wade—and now they are endangering access to medication abortion for more than 64.5 million people – even in states where abortion is protected. This is a five-alarm fire, and we should all be on high alert. In order to preserve any last shred of its legitimacy, the Court must rule against anti-abortion extremists’ bogus case.”
Reproductive Freedom for All and its more than 4 million members nationwide will continue to organize to hold anti-abortion extremists accountable for the harm they’ve caused to countless people across the country. We remain committed to defending access to this safe, effective medication, including through the People’s Petition.
###
For over 50 years, Reproductive Freedom for All (formerly NARAL Pro-Choice America) has fought to protect and advance reproductive freedom at the federal and state levels—including access to abortion care, birth control, pregnancy and post-partum care, and paid family leave—for everybody. Reproductive Freedom for All is powered by its more than 4 million members from every state and congressional district in the country, representing the 8 in 10 Americans who support legal abortion.